A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
Clinical trial NCT02288559 · COMPLETED
Trial details
- NCT number
- NCT02288559
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-30
- Primary completion
- 2017-06-02
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.